Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

James M Allan; Alexandra G Smith; Keith Wheatley; Robert K Hills; Lois B Travis; Deirdre A Hill; David M Swirsky; Gareth J Morgan; Christopher P Wild

doi:10.1182/blood-2004-06-2161

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

Identifier:nobleid.org/w1/20260515/ECC4FE9D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ECC4FE9D.svg?ark=w1%2F20260515%2FECC4FE9D)](https://nobleid.org/work/w1/20260515/ECC4FE9D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

Identifier:nobleid.org/w1/20260515/ECC4FE9D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ECC4FE9D.svg?ark=w1%2F20260515%2FECC4FE9D)](https://nobleid.org/work/w1/20260515/ECC4FE9D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work